The Data Hub
A Source for Real-World Hematology Data
Together, we can improve the quality of life for individuals affected by sickle cell disease (SCD). The Data Hub, as a centralized data source, is improving access to quality clinical data. The ASH Research Collaborative™ is working with the SCD community to remove barriers to research participation and quality improvement. The goal is to make research faster and more impactful.
The Data Hub’s SCD Program includes a Learning Community, a network of sites that contribute data and share best practices to improve patient outcomes. All participating Data Hub sites are invited to join the SCD Learning Community in 2023.
The Data Hub Sickle Cell Disease Program includes prominent sickle cell disease research institutions and medical centers in the United States.
The Data Hub uses clinical concepts and data elements for electronic health record codes that align with the most recent United States Core Data for Interoperability (USCDI) standards. This minimizes the data collection burden for participating sites, as all certified electronic health record vendors, providers, and payers are already required to make these elements available for data exchange.
These USCDI entities are included in collaborating sites’ data submissions:
We aim to make submission easy through our data submission pathways and models.
Participating sites have access to their own confidential Data Hub Site Portal.
Site Portal tools include:
Near real-time observational summaries are available on the disease-specific Dashboard. Sites can track their own patients, analyze outcomes, and identify ways to improve the quality of care provided to those living with SCD.
The disease-specific Dashboard presents metrics across seven clinical categories that are most valuable for SCD researchers and clinicians to track.
These metrics were established by the Data Hub’s SCD Subcommittee through an iterative process informed by clinicians, regulators, payers, health technology experts, biotech companies, the U.S. Food and Drug Administration and the National Heart, Lung, and Blood Institute.
Below are the clinical categories:
View the metrics that sites can track on the Disease-Specific Dashboard.